Sabra Health Care Reit Inc Stock Price, News & Analysis

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced the release date for its 2023 first quarter earnings on May 3, 2023, after trading closes. A conference call will follow on May 4 at 10:00 a.m. PT, allowing investors to discuss the results. U.S. participants can dial in at 888-880-4448, while international participants can reach 646-960-0572, using conference ID 1382596. The event will be webcasted and available for replay on Sabra's website. As a self-managed REIT, Sabra invests in healthcare-related real estate across the U.S. and Canada.

Sabra Health Care REIT (Nasdaq: SBRA) reported a net loss of $(0.37 per diluted share for Q4 2022, alongside FFO of $0.25 and normalized FFO of $0.37. The company transitioned a 24-property portfolio to The Ensign Group and Avamere, generating $34.5 million in initial annual rent. They also acquired an 85% interest in three Canadian senior housing communities for $52.1 million with a 7.6% yield. Seven skilled nursing facilities were disposed of, yielding $25.9 million in gross proceeds. As of December 31, 2022, liquidity stood at $852.3 million. The Board declared a quarterly cash dividend of $0.30 per share, payable on February 28, 2023.

Sabra Health Care REIT (SBRA) announced that CEO Rick Matros will present at the WISE Forum on February 28, 2023, in Rancho Santa Fe, California. Other attendees include Chief Investment Officer Talya Nevo-Hacohen and Executive VP of Investments Darrin Smith. The company is also participating in the NIC Spring Conference from March 1-3, 2023, in San Diego, California, with the same executives attending. Additionally, they will take part in Citi's Global Property CEO Conference from March 5-8, 2023, in Hollywood, Florida. Sabra operates as a self-administered and self-managed REIT focused on healthcare real estate across the U.S. and Canada.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has announced gross proceeds of approximately $185 million from disposition activities since September 30, 2022. This includes a significant portfolio of skilled nursing properties sold for over $200,000 per bed, yielding around 7% cash yield for the year ending September 30, 2022. The net proceeds were applied to reduce borrowings under the revolving credit facility. Additionally, 24 properties transitioned from North American to Ensign (Nasdaq: ENSG) and Avamere. CEO Rick Matros highlighted the commitment to capital allocation and balance sheet management amid an uncertain macro environment.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) will release its 2022 fourth quarter earnings on February 21, 2023, after trading closes. A conference call to discuss the results is scheduled for February 22 at 10:00 a.m. Pacific Time, with U.S. participants using the number 888-880-4448. A quarterly cash dividend of $0.30 per share has been declared, payable on February 28, 2023, for shareholders of record by February 13. Visit www.sabrahealth.com for more details.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has announced the tax treatment for its 2022 cash distributions. The total distribution per share is $1.20, which includes $0.87 categorized as ordinary dividends. The dividends consist of $0.22 as non-qualified and $0.08 as qualified dividends. Shareholders need to hold their shares for at least 45 days for dividends to qualify under Section 199A. The company also reported amounts for applicable partnership interests as $0.00. Investors are advised to consult tax advisors regarding the tax implications of these distributions.